Inventor · disambiguated record
Jonathan William Medley
Also filed as: MEDLEY JONATHAN W · MEDLEY JONATHAN WILLIAM
26 granted patents·14 pending applications·54 citations·filing 2017–2025
94Inventor score
Files withGILEAD SCIENCES INC40
Top patents by PatentIndex Score
40 records- 0197US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0296US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0396US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0495US11773122B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·4 cites·38 claims
- 0593US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 0693US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 0792US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 0891US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0990US12054490B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Aug 6, 2024·1 cites·20 claims
- 1089US11845723B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Dec 19, 2023·3 cites·41 claims
- 1187US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 1287US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1383US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 1482US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 1582US12030904B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 9, 2024·0 cites·18 claims
- 1681US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1780US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 1880US2025361236A9Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1978US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2077US12448400B2KRAS G12D modulating compoundsGILEAD SCIENCES INC·Filed 2024·Granted Oct 21, 2025·0 cites·15 claims
- 2177US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 2277US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 2377US11963967B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Apr 23, 2024·0 cites·51 claims
- 2476US12473314B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 18, 2025·0 cites·33 claims
- 2571US2025109147A1Kras g12d modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2670US2021251957A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2769US2023339981A1Kras g12d modulating compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2868US2023374036A1Kras g12d modulating compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2967US2025230168A1Azaspiro wrn inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3066US12208110B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 3166US2025059208A1Kras modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3266US2025101042A1Kras g12d modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3364US2025042922A1Kras modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3462US2024383922A1KRAS Modulating CompoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3560US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 3660US11999733B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Jun 4, 2024·0 cites·19 claims
- 3759US11926628B2Diacylglyercol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 3848US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3947US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 4046US11236085B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Feb 1, 2022·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Jonathan William Medley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →